Danish Biotech Samplix Secures €25 Million First Close to Scale Single-Cell Platform

Danish biotech Samplix announced a €25 million first close of its financing round, led by WLanholding GmbH. The funds will be used to scale the Xdrop droplet microfluidics platform for antibody discovery and to explore AI‑driven drug discovery. The round includes €3 million in new equity and €22 million in convertible bonds, with a total target of €30 million. Dr. Werner Lanthaler of WLan will join Samplix’s board, supporting the company’s next growth phase.

Finnish Insect Protein Producer Volare Opens Industrial Factory, Secures €7.1 Million in Series B Funding

Finnish startup Volare, founded in 2021, has completed its first 10,000 m² industrial insect‑protein plant in Pori, delivering €15 million of CAPEX on schedule and within budget. The company raised €7.1 million from Springvest and Maki.vc to scale the facility, which can produce up to 5,000 t of insect protein and 2,000 t of insect oil annually, and plans to replicate the model throughout Europe.

General Intuition Leads Dutch Startup Investment Surge With $220 Million Series B Round

The Q3 2026 Dutch startup ecosystem attracted €799 million in published investments, a 77 % increase over 2025. The quarter was led by two mega‑rounds, including General Intuition’s $220 million raise and Euclyd’s €200 million raise, highlighting the outsized impact of a few large deals on the overall market.

Cambridge Photonics Firm Salience Labs Raises $125 Million for AI Datacenter Optical Switching Expansion

Salience Labs, a Cambridge‑based developer of photonic chips for AI data‑centre connectivity, secured $125 million in a Series B round led by Bullhound Capital with participation from AMD Ventures, Intel Capital, SBI Group, Hudson River Trading, British Business Bank and existing backers. The funding will be used to scale manufacturing, roll out its optical circuit switching technology, and expand its engineering team and geographic presence.

London-based Scarlet raises $50M Series B to expand AI medical device certification globally

Scarlet, a London‑based certification body specialized in AI and software medical devices, closed a $50 million Series B led by Headline. The funding will support its expansion into the US and APAC markets, increase its team of AI reviewers, and extend its certification services, positioning it as the only EU‑designated notified body focused on AI‑native medical devices.

Sava Technologies Secures €32.08 Million Series B to Advance Next-Generation Glucose Microsensor in Europe

London‑based health‑tech startup Sava Technologies secured a €32.08 million Series B round led by Ascensia, bringing its next‑generation glucose microsensor closer to European market launch. The funding will be used to scale manufacturing and prepare for commercial rollout, while the partnership with Ascensia provides distribution and commercialization expertise across Europe.

AI Evaluation Platform Arena Raises $200 Million in Series B, Hits $3.1 Billion Valuation

Arena, the AI evaluation platform co‑founded by Romanian professor Ion Stoica, closed a $200 million Series B round led by Lightspeed Venture Partners and Khosla Ventures, pushing its valuation to $3.1 billion and funding the launch of an Alignment Index and further hiring.

SAP Acquires Belgian AI Startup TechWolf in Landmark Deal for European Tech Scene

German software giant SAP announced the acquisition of Belgian AI‑driven workforce analytics startup TechWolf. The deal, undisclosed in value, is described as the biggest venture‑backed software acquisition in Belgium. TechWolf, founded in 2018 and backed by investors such as Felix Capital and Notion Capital, will become part of SAP’s talent and workforce strategy.